Quick Summary — ANNA scores higher on quality with 7.2/10 vs AMPY's 3.9/10. AMPY trades at $4.77 while ANNA trades at $3.33. Both analyzed daily using SEC EDGAR data across 13 institutional models.
ANNA scores higher with a 7.2/10 quality rating vs AMPY's 3.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.
At $4.77, AMPY trades +337.6% below its Bayesian DCF fair value of $20.88, while ANNA at $3.33 trades +70.7% above its estimate of $0.98. AMPY shows a wider gap between price and intrinsic value.
AMPY earns a Quality of Company score of 3.9/10 compared to ANNA's 7.2/10. This is a significant quality gap — the higher-scoring company demonstrates materially stronger fundamentals across profitability, growth consistency, and balance sheet health. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.
AMPY carries a SAFE value trap risk (12/100) while ANNA shows SAFE risk (10/100). Both companies show manageable value trap risk, suggesting their current valuations are not artificially depressed by fundamental deterioration.
Both AMPY and ANNA operate in Oil & Gas E&P, which has 4 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).
11 hidden models compare AMPY vs ANNA differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.
Bloomberg Terminal: ~$2,000/mo · FactSet: ~$1,000/mo · CirclFi: $0.90/day
See All 13 Models — $0.90/dayWe don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.